B. Semih Et Al. , "Tyrosine kinase inhibitors and COVID-19," Journal of Oncology Pharmacy Practice , vol.26, no.8, pp.2072-2073, 2020
Semih, B. Et Al. 2020. Tyrosine kinase inhibitors and COVID-19. Journal of Oncology Pharmacy Practice , vol.26, no.8 , 2072-2073.
Semih, B., Tuğçe Nur, Y., Mehmet Sinan, D., Serdal, K., Burhan, T., & Fevzi, A., (2020). Tyrosine kinase inhibitors and COVID-19. Journal of Oncology Pharmacy Practice , vol.26, no.8, 2072-2073.
Semih, SEMİH Et Al. "Tyrosine kinase inhibitors and COVID-19," Journal of Oncology Pharmacy Practice , vol.26, no.8, 2072-2073, 2020
Semih, SEMİH Et Al. "Tyrosine kinase inhibitors and COVID-19." Journal of Oncology Pharmacy Practice , vol.26, no.8, pp.2072-2073, 2020
Semih, B. Et Al. (2020) . "Tyrosine kinase inhibitors and COVID-19." Journal of Oncology Pharmacy Practice , vol.26, no.8, pp.2072-2073.
@article{article, author={SEMİH BAŞCI Et Al. }, title={Tyrosine kinase inhibitors and COVID-19}, journal={Journal of Oncology Pharmacy Practice}, year=2020, pages={2072-2073} }